BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37823234)

  • 1. Chinese adaptation and validation of the chronic rhinosinusitis-patient-reported outcome: Assessment of health-related quality-of-life.
    Chen J; Hu L; Zhang C; Shi L; Zhang Q; Zhou Y; Cheng F; Gao Y; Li H; Wang D; Wang H; Sun X
    Int Forum Allergy Rhinol; 2024 May; 14(5):950-960. PubMed ID: 37823234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness and convergent validity of the chronic rhinosinusitis patient-reported outcome (CRS-PRO) measure in CRS patients undergoing endoscopic sinus surgery.
    Lin KA; Price CPE; Huang JH; Ghadersohi S; Cella D; Kern RC; Conley DB; Shintani-Smith S; Welch KC; Tan BK
    Int Forum Allergy Rhinol; 2021 Sep; 11(9):1308-1320. PubMed ID: 33728827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Preliminary Validation of a New Patient-Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO).
    Ghadersohi S; Price CPE; Jensen SE; Beaumont JL; Kern RC; Conley DB; Welch KC; Peters AT; Grammer LC; Stevens WW; Calice AM; Stanton E; VanderMeeden MK; Schleimer RP; Tan BK
    J Allergy Clin Immunol Pract; 2020; 8(7):2341-2350.e1. PubMed ID: 32376490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
    Fokkens W; Trigg A; Lee SE; Chan RH; Diamant Z; Hopkins C; Howarth P; Lund V; Mayer B; Sousa AR; Yancey S; Tabberer M;
    J Patient Rep Outcomes; 2023 Jan; 7(1):4. PubMed ID: 36662344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness and Convergent Validity of a New Patient-Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO).
    Ghadersohi S; Price CPE; Beaumont JL; Kern RC; Conley DB; Welch KC; Calice AM; Stanton E; VanderMeeden MK; Jensen SE; Peters AT; Grammer LC; Stevens WW; Schleimer RP; Tan BK
    J Allergy Clin Immunol Pract; 2020; 8(7):2351-2359.e2. PubMed ID: 32361009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-cultural adaptation and validation of the 22-item sinonasal outcome test (SNOT-22) in German-speaking patients: a prospective, multicenter cohort study.
    Albrecht T; Beule AG; Hildenbrand T; Gerstacker K; Praetorius M; Rudack C; Baumann I
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2433-2439. PubMed ID: 34351466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast levels are increased in chronic rhinosinusitis with nasal polyps and are associated with worse subjective disease severity.
    Carroll WW; O'Connell BP; Schlosser RJ; Gudis DA; Karnezis TT; Lawrence LA; Soler ZM; Mulligan JK
    Int Forum Allergy Rhinol; 2016 Feb; 6(2):162-8. PubMed ID: 26370180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of health-related quality-of-life in patients with chronic Rhinosinusitis - Validation of the German Sino-Nasal Outcome Test-22 (German-SNOT-22).
    Riedl D; Dejaco D; Steinbichler TB; Innerhofer V; Gottfried T; Bektic-Tadic L; Giotakis AI; Rumpold G; Riechelmann H
    J Psychosom Res; 2021 Jan; 140():110316. PubMed ID: 33271403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Rhinosinusitis Patients With and Without Polyps Experience Different Symptom Perception and Quality of Life Burdens.
    Talat R; Speth MM; Gengler I; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
    Am J Rhinol Allergy; 2020 Nov; 34(6):742-750. PubMed ID: 32437223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sino-nasal outcome test (SNOT)-22: validation for Greek patients.
    Lachanas VA; Tsea M; Tsiouvaka S; Hajiioannou JK; Skoulakis CE; Bizakis JG
    Eur Arch Otorhinolaryngol; 2014 Oct; 271(10):2723-8. PubMed ID: 24595707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-specific differences in chronic rhinosinusitis patients electing endoscopic sinus surgery.
    Lal D; Rounds AB; Divekar R
    Int Forum Allergy Rhinol; 2016 Mar; 6(3):278-86. PubMed ID: 26574907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sino-Nasal Outcome Test-22: Translation, Cross-cultural Adaptation, and Validation in Hebrew-Speaking Patients.
    Shapira Galitz Y; Halperin D; Bavnik Y; Warman M
    Otolaryngol Head Neck Surg; 2016 May; 154(5):951-6. PubMed ID: 26908555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sino-nasal outcome test-22: Cross-cultural adaptation and validation in Russian speaking patients.
    Eisenbach N; Matot S; Nemet A; Sela E; Marshak T; Ronen O
    Clin Otolaryngol; 2020 May; 45(3):350-356. PubMed ID: 31967705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between computed tomography staging and quality of life instruments in patients with chronic rhinosinusitis.
    Zheng Y; Zhao Y; Lv D; Liu Y; Qiao X; An P; Wang D
    Am J Rhinol Allergy; 2010; 24(1):e41-5. PubMed ID: 20109323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-cultural adaptation and validation of the SNOT-22 into Italian.
    Mozzanica F; Preti A; Gera R; Gallo S; Bulgheroni C; Bandi F; Ottaviani F; Castelnuovo P
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):887-895. PubMed ID: 27677485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Sinonasal Outcome Test (SNOT-22) Domains in Chronic Rhinosinusitis With Nasal Polyps.
    Khan AH; Reaney M; Guillemin I; Nelson L; Qin S; Kamat S; Mannent L; Amin N; Whalley D; Hopkins C
    Laryngoscope; 2022 May; 132(5):933-941. PubMed ID: 34437720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRS-PRO and SNOT-22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis.
    Racette SD; Schneider AL; Ganesh M; Huang JH; Lehmann DS; Price CPE; Rodegherio SG; Reddy AT; Eide JG; Conley DB; Welch KC; Kern RC; Shintani-Smith S; Kato A; Schleimer RP; Tan BK
    Int Forum Allergy Rhinol; 2022 Nov; 12(11):1377-1386. PubMed ID: 35363947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights.
    Dejaco D; Riedl D; Huber A; Moschen R; Giotakis AI; Bektic-Tadic L; Steinbichler T; Kahler P; Riechelmann H
    Eur Arch Otorhinolaryngol; 2019 May; 276(5):1355-1365. PubMed ID: 30739177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the Sino-Nasal Outcome Test 22 and visual analog scale symptom scores in chronic rhinosinusitis with and without nasal polyps.
    Gregurić T; Trkulja V; Baudoin T; Grgić M; Šmigovec I; Kalogjera L
    Am J Rhinol Allergy; 2016; 30(2):107-12. PubMed ID: 26980391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating metrics of responsiveness using patient-reported outcome measures in chronic rhinosinusitis.
    Lidder AK; Detwiller KY; Price CP; Kern RC; Conley DB; Shintani-Smith S; Welch KC; Chandra RK; Peters AT; Grammer LC; Man LX; Schleimer RP; Tan BK
    Int Forum Allergy Rhinol; 2017 Feb; 7(2):128-134. PubMed ID: 28177596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.